Evaluation of peritoneal transport and membrane status in peritoneal dialysis: Focus on incident fast transporters

American Journal of Nephrology

Volumn 27, Issue 1, 2007, Pages 84-91

  Rodrigues, Anabela S ^a,c   Martins, Margarida ^a   Korevaar, Johanna C ^b   Silva, Sandra ^a   Oliveira, José C ^a   Cabrita, Antonio ^a   Castro E Melo, João ^a   Krediet, Raymond T ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

CA 125; Interleukin 6; Mesothelial cells; Peritoneal transport; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CREATININE; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIALYSATE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

ASCITIC FLUID; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT, ACTIVE; CA-125 ANTIGEN; DIALYSIS SOLUTIONS; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS; PROGNOSIS; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847666021     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099332     Document Type: Article

References (36)

1. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW: Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004;43:492-501.
2. Szeto CC, Law MC, Wong TY, Leung CB, Li PK: Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis 2001;37:329-336.
3. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, Lee HB: Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000;20:541-547.
4. Chung SH, Heimburger O, Stenvinkel P, Bergström J, Lindholm B: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001;16:2240-2245.
5. Pecoits-Filho R, Carvalho MJ, Stenvinkel P, Lindholm B, Heimburger O: Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int 2006;26:53-63.
6. Krediet RT, Zweers MM, van der Wal AC, Struijk DG: Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000;20(Suppl 2):S19-S25.
7. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN: Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int 2000;20:14-18.
8. Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006;17:271-278.
9. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006;17:2591-2598.
10. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B: Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003;18:590-597.
11. Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, Correia C, Santos MJ, Cabrita A: Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated to systemic inflammation. Nephrol Dial Transplant 2006;21:763-769.
12. Van Esch S, Zweers MM, Jansen MA, de Waart DR, van Manen JG, Krediet RT: Determinants of peritoneal solute transport rates in newly started non-diabetic peritoneal dialysis patients. Perit Dial Int 2004;24:554-561.
13. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S; Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
14. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B: Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent dialysis patients. Perit Dial Int 2003;23:74-83.
15. Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY: Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoneal transport status. Perit Dial Int 2001;21(Suppl 3):S80-S85.
16. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT: Predictors of poor outcome in chronic dialysis patients: The Netherlands' Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 2000;35:69-79.
17. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ: Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function. Perit Dial Int 2002;22:371-379.
18. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, Bos WJ, Krediet RT: Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands' Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 1999;55:1476-1485.
19. Krediet RT: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001;21:560-567.
20. Ha H, Cha MK, Choi HN, Lee HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002;22:171-177.
21. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002;61:570-578.
22. Rodrigues AS, Martins M, Santos MJ, Fonseca I, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT: Evaluation of effluent markers CA 125, VEGF and IL-6: relationship with peritoneal transport. Adv Perit Dial 2004;20:8-12.
23. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
24. Davies SJ: Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004;66:2437-2445.
25. del Peso G, Fernandez-Reyes MJ, Hevia C, Bajo MA, Castro MJ, Cirugeda A, Sanchez-Tomero JA, Selgas R: Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant 2005;20:1201-1206.
26. Davies SJ: Getting to grips with individual variation in membrane function. Perit Dial Int 2005;25:35-37.
27. Breborowicz A, Breborowicz M, Pyda M, Polubinska A, Oreopoulos D: Limitations of CA125 as an index of peritoneal mesothelial cell mass. Nephron Clin Pract 2005;100:c46-c51.
28. Senger DR: Molecular framework for angiogenesis. A coupled web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 1996;149:1-7.
29. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993;43:226-233.
30. Topley N, Mackenzie R, Jörres A, Coles GA, Davies M, Williams JD: Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity. Perit Dial Int 1993;13(Suppl 2):S82-S85.
31. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romão JE Jr, Marcondes M, De Oliveira AH, Noronha IL: Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002;17:1480-1486.
32. Johansson AC, Haraldsson B: Physiological properties of the peritoneum in an adult peritoneal dialysis population over a threeyear period. Perit Dial Int 2006;26:482-489.
33. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimburger O, Lindholm B, Nordfors L, Robert A, Devuyst O: Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005;67:2477-2487.
34. Parikova A, Smit W, Struijk DG, Zweers MM, Krediet RT: The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. Kidney Int 2005;68:1849-1856.
35. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT: Longitudinal follow-up of CA125 in peritoneal effluent. Kindey Int 1997;51:888-893.
36. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sanchez-Tomero JA, Jimenez-Heffernan JA, Lopez-Cabrera M: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005;46:938-948.